Correlation Between Tarsus Pharmaceuticals and Joint Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Joint Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Joint Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and The Joint Corp, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Joint Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Joint Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Joint Corp.

Diversification Opportunities for Tarsus Pharmaceuticals and Joint Corp

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Tarsus and Joint is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and The Joint Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Joint Corp and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Joint Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Joint Corp has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Joint Corp go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Joint Corp

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.02 times more return on investment than Joint Corp. However, Tarsus Pharmaceuticals is 1.02 times more volatile than The Joint Corp. It trades about 0.37 of its potential returns per unit of risk. The Joint Corp is currently generating about 0.02 per unit of risk. If you would invest  3,289  in Tarsus Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  1,795  from holding Tarsus Pharmaceuticals or generate 54.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  The Joint Corp

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Joint Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in The Joint Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Joint Corp is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Tarsus Pharmaceuticals and Joint Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Joint Corp

The main advantage of trading using opposite Tarsus Pharmaceuticals and Joint Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Joint Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Joint Corp will offset losses from the drop in Joint Corp's long position.
The idea behind Tarsus Pharmaceuticals and The Joint Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences